We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Helen Moon

Helen H. Moon MD

Medical Oncology Lead, GU Oncology, Southern California Permanente Medical Group, Kaiser Permanente, Riverside, California

Recent Contributions to PracticeUpdate:

  1. Prostate Cancer in the COVID Era: Systemic Therapy for mCRPC
  2. Bladder Cancer in the COVID Era: Metastatic Cancers and the Role of Clinical Trials
  3. Prostate Cancer in the COVID Era: Radiation Therapy for mCRPC
  4. Bladder Cancer in the COVID Era: Locally Advanced Muscle Invasive Cancer
  5. Prostate Cancer in the COVID Era: Metastatic Hormone-Sensitive Prostate Cancer
  6. Prostate Cancer in the COVID-19 Era: Localized Prostate Cancer
  7. Bladder Cancer in the COVID Era: Non-Muscle Invasive Cancer
  8. RCC in the COVID Era: Early-Stage Operable Cancer
  9. RCC in the COVID Era: Immunotherapy for Metastatic Cancer
  10. RCC in the COVID Era: Clinical Trials and Referrals

Most Read This Week

Recently Updated